Nephron Physiology 1989-01-01

Furosemide accelerates gentamicin accumulation in cultured renal cells (LLC-PK1 cells).

H Nakahama, Y Fukuhara, Y Orita, A Yamauchi, T Takama, T Kamada

Index: Nephron 53(2) , 138-41, (1989)

Full Text: HTML

Abstract

Furosemide is known to potentiate gentamicin nephrotoxicity. The mechanism of potentiation is unclear. In our previous studies, we demonstrated that furosemide enhanced gentamicin accumulation in rabbit renal tissues when injected as a bolus [Kidney int. 33:363, 1988] or repeatedly subcutaneously [Diuretics II, Elsevier, New York 1987, pp.693]. In this study, we evaluated the effects of furosemide on gentamicin accumulation in cultured renal cells (LLC-PK1) and hepatoma cells (H4IIE). Thus, we excluded effects secondary to furosemide-elicited hemodynamic changes. Seven days after seeding, the culture medium was exchanged for medium containing 1 mM gentamicin alone [G] or 1 mM gentamicin +1 mM furosemide [GF]. In LLC-PK1 cells, gentamicin concentration in [GF] was significantly higher than that in [G], while gentamicin was not detected in H4IIE cells with or without furosemide. We conclude that furosemide can accelerate gentamicin accumulation in renal tissues and potentiate gentamicin nephrotoxicity.


Related Compounds

Related Articles:

The use of HPLC to elucidate the metabolism and urinary excretion of furosemide and its metabolic products.

1981-09-01

[Acta Pharmacol. Toxicol. (Copenh.) 49(3) , 223-9, (1981)]

The binding of furosemide to serum proteins in elderly patients: displacing effect of phenprocoumon.

1980-09-01

[Acta Pharmacol. Toxicol. (Copenh.) 47(3) , 202-7, (1980)]

Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.

1980-01-01

[Drug Metab. Dispos. 8(5) , 337-42, (1980)]

The urinary excretion of frusemide and its metabolites by kidney transplant patients.

1987-01-01

[Eur. J. Clin. Pharmacol. 32(3) , 313-5, (1987)]

Microbial models of mammalian metabolism. N-dealkylation of furosemide to yield the mammalian metabolite CSA using Cunninghamella elegans.

1992-01-01

[Drug Metab. Dispos. 20(6) , 882-8, (1992)]

More Articles...